Roche bets on China with $468m Dx test facility in China
This article was originally published in Clinica
Executive Summary
Capitalizing on China’s increasing demand for lab testing services, Roche is planning to inject CHF450m ($468m) to build a new diagnostics plant in Suzhou Industry Park in Suzhou, Jiangsu province. The plant is Roche’s first in Asia and it will focus on producing immunochemistry and clinical chemistry tests and products that will meet the need for clinical lab testing as China continues to invest in health care.